Zei et al., 1991 - Google Patents
Immunogenicity of trivalent subunit and split influenza vaccines (1989–90 winter season) in volunteers of different groups of ageZei et al., 1991
- Document ID
- 15401060653449192029
- Author
- Zei T
- Neri M
- Iorio A
- Publication year
- Publication venue
- Vaccine
External Links
Snippet
Trivalent split or subunit influenza vaccines [A/Shangai/11/87 (H3N2), A/Singapore/6/86 (H1N1) and B/Yamagata/16/88] recommended for the 1989–90 winter season and licensed in Italy, were administered to 149 volunteers of three different age groups (elderly, middle …
- 229960003971 Influenza vaccines 0 title abstract description 15
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zei et al. | Immunogenicity of trivalent subunit and split influenza vaccines (1989–90 winter season) in volunteers of different groups of age | |
| Sui et al. | Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant | |
| US7052701B2 (en) | Inactivated influenza virus vaccine for nasal or oral application | |
| Mumford et al. | Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8) | |
| KR100703571B1 (en) | Peptide-based vaccine for influenza | |
| JP3530526B2 (en) | Herpes simplex vaccine comprising HSV glycoprotein gD and 3 deacylated monophosphoryl lipid A | |
| Webster et al. | Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus | |
| US4009258A (en) | Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same | |
| Couch | Orthomyxoviruses | |
| Welter et al. | Mucosal vaccination with recombinant poxvirus vaccines protects ferrets against symptomatic CDV infection | |
| Wang et al. | Evaluation of immune effects of fowlpox vaccine strains and field isolates | |
| Charles et al. | Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate | |
| Paillot et al. | Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding | |
| US20230374469A1 (en) | Beta coronavirus cold acclimatized strain and vaccine | |
| KR101654023B1 (en) | Live vaccine composition, inactivated vaccine composition and oral vaccine comprising the same from currently isolated attenuated porcine epidemic diarrhea virus | |
| Wang et al. | A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge | |
| Ben-Yedidia et al. | Efficacy of anti-influenza peptide vaccine in aged mice | |
| Bastien et al. | Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines | |
| Ma et al. | Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18 | |
| Klein et al. | Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice | |
| Mwirigi et al. | Experimental evaluation of inactivated and live attenuated vaccines against Mycoplasma mycoides subsp. mycoides | |
| Butchko et al. | Specificity studies on the proliferative response of thymus-derived lymphocytes to influenza viruses | |
| Marcano et al. | Evaluation of chickens infected with a recombinant virulent NDV clone expressing chicken IL4 | |
| Jayawardane et al. | Oral vaccination of chickens against Newcastle disease with V4 vaccine delivered on processed rice grains | |
| Jackson et al. | Viruses causing common respiratory infections in man. II. Enteroviruses and paramyxoviruses |